TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹367 Cr | ₹281 Cr | ₹688 Cr | ₹544 Cr | ₹744 Cr |
What is the latest Capital Work in Progress ratio of TORRENT PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹281 Cr |
| Mar2023 | ₹688 Cr |
| Mar2022 | ₹544 Cr |
| Mar2021 | ₹744 Cr |
How is Capital Work in Progress of TORRENT PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹367 Cr | 30.79 | |
| Mar2024 | ₹281 Cr | -59.20 | |
| Mar2023 | ₹688 Cr | 26.44 | |
| Mar2022 | ₹544 Cr | -26.83 | |
| Mar2021 | ₹744 Cr | - | |
Compare Capital Work in Progress of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹146,931.6 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
| MANKIND PHARMA | ₹91,867.7 Cr | 2.3% | 6.7% | -3.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.8% |
8.8% |
44.3% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses